Donor Screening During a Global Pandemic
COREY BURKE

In 2005, Burke was trained in the relatively new technology of vitrification of embryos and oocytes. This technology produced increased survival rates with embryos, and for the first time allowed oocytes to be effectively and efficiently cryopreserved. Over the next fourteen years he started several fertility preservation programs and worked as a training consultant for a large commercial donor egg bank. He has vitrified tens of thousands of oocytes resulting in hundreds of children. Serving on the American Association of Bioanalyst Legislative Committee, two FDA workshop committees, and the scientific advisory board of a large biotechnology company, Burke is an industry thought leader.